In this present work, we studied the response to individual and combinatorial MYC and KRAS targeting PPRHs in KRAS and MYC-deregulated, dependent, and sensitive prostate PC-3 and pancreatic AsPc-1 cancer cells. Here, KRAS is linked to cancer.